TTAB Oppositions 91215252
USPTO Oppositions proceeding 91215252, filed 2014-03-04. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91215252 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2014-03-04 |
| Last Activity | 2014-12-17 |
| Days Active | 4454 |
Parties
- Actavis Group PTC ehf — Defendant
- Genentech, Inc. — Plaintiff
Plaintiff Marks
- ACTIVASE — Genentech, Inc.
- ACTIVASE ALTEPLASE A RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR THE ONE T-PA FOR STROKE — Genentech, Inc.
- CATHFLO ACTIVASE (ALTEPLASE) THE ONE 2-MG T-PA — Genentech, Inc.
Defendant Marks
- ACTAVIS PHARMACEUTICALS — Actavis Group PTC ehf
Recent Documents
- 2014-12-17: TERMINATED — Status
- 2014-12-17: BD DECISION: DISMISSED W/O PREJ — Decisions
- 2014-12-11: MOT TO AMEND APPLICATION — Motions
- 2014-10-07: SUSPENDED — Status
- 2014-10-06: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2014-07-07: SUSPENDED — Status
- 2014-07-07: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2014-04-08: SUSPENDED — Status
- 2014-04-08: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2014-03-04: PENDING, INSTITUTED — Status
- 2014-03-04: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2014-03-04: FILED AND FEE — Fees